Shirley Ryan AbilityLab

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

1 drugs in development

Approved1

Phase 21

Preclinical1

By Therapeutic Area

top 2

Cardiovascular

150%

Neurology

150%

R&D Momentum

50/100

Pipeline Velocity

19/100

Trial Completion Rate

50/100

Pipeline Concentration

50/100

Pipeline Freshness

39/100

Strategic Signals

↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Oct 23, 2026

Enrolling by invitation

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

Oct 23, 2026

Active, not recruiting

Investigational Study of the Ekso Powered Exoskeleton for Ambulation in Individuals With Spinal Cord Injury (or Similar Neurological Weakness)

Earlier

Oct 21, 2026TrialLocomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke

Oct 21, 2026TrialWearable Sensor Platform to Monitor Stroke Recovery During Inpatient Rehabilitation

Oct 21, 2026TrialEvaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

Oct 15, 2026TrialPaired Stimulation Plasticity for Motor Recovery in Humans With and Without Spinal Cord Injury

Oct 10, 2026TrialTherapeutic Benefits of Pareidolia in Acute Traumatic Brain Injury Patients

Oct 9, 2026TrialA Wearable Sensor Toolkit for Automated Home Evaluations of Infant Motor Development

4 more events

Aug 8, 2026TrialMultimodal Haptic Feedback for Plantar Sensory Substitution

Aug 1, 2026TrialEarly Detection and Therapeutic Improvement of Motor Delay in High Risk Infants: A Randomized, Controlled Trial

Jul 15, 2026TrialHuman-like Robotic Controllers for Enhanced Motor Learning

Jul 15, 2026TrialSensory-specific Peripheral Stimulation for Tremor Management

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

AmpyraApproved

Neurology

Cerebellar Ataxia

AmpyraPreclinical

Hereditary Spastic Paraplegia

AmpyraPreclinical

Spinal Cord Injury

AmpyraPhase 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)